Metabolic syndrome in children and adolescents: Doubts about terminology but not about cardiometabolic risks;Síndrome metabólica em crianças e adolescentes: Dúvidas na terminologia, mas não nos riscos cardiometabólicos

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 55, Issue 8, 2011, Pages 576-582

  Damiani, Durval ^a   Kuba, Valesca Mansur ^b   Cominato, Louise ^a   Damiani, Daniel ^c   Dichtchekenian, Vaê ^a   de Menezes Filho, Hamilton Cabral ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c MASTERS AND DOCTORAL PROGRAMS IN PHYSICAL THERAPY   (Brazil)

Author keywords

Body mass index; Dyslipidemia; Hepatic steatosis; Insulin resistance; Metabolic syndrome; Systemic hypertension

Indexed keywords

ADOLESCENT; CARDIOVASCULAR DISEASE; CHILD; HUMAN; METABOLIC SYNDROME X; NOMENCLATURE; OBESITY; REVIEW; RISK FACTOR;

ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; HUMANS; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; TERMINOLOGY AS TOPIC;

EID: 84855461157     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302011000800011     Document Type: Review

References (30)

1. Nelson RA, Bremer AA. Insulin resistance and metabolic syndrome in the pediatric population. Metab Syndr Relat Disord. 2010;8(1):1-14.
2. Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Curr Diab Rep. 2004;4(1):53-62.
3. Spicuzza L, Leonardi S, La Rosa M. Pediatric sleep apnea: early onset of the "syndrome"? Sleep Med Rev. 2009;13:111-22.
4. Fernandez JR, Reddent D T, Pietrobelli A, Allison DB. Waist cir-cunference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004:145(4):439-44.
5. Katzmarzyk PT. Waist circunference percentiles for canadian youth 11-18 of age. Eur J Clin Nutr. 2004;58(7):1011-5.
6. Maffeis C, Pietrobelli A, Grezzani A, Provera S, Tatol L. Waist cir-cunference and cardiovascular risk factors in prepubertal children. Obes Res. 2001;9(3):179-87.
7. Carr DB, Utzasghneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53(8):2087-94.
8. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23): 2362-74.
9. Mokha JS, Srinivasan SR, DasMahapatra P, Fernandez C, Chen W, Xu J, et al. Utility of waist-to-height ratio in assessing the satatus of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: The Bogalusa Heart Study. Pediatrics. 2010;10:73-9.
10. Fisberg M, Cintra T P, Costa R F, Santos LC. Obesidade infanto-ju-venil: epidemiologia, diagnóstico, composição corporal e trata-mento. In: Setian N, et al. Obesidade na criança e no adolescente. 1.ed. São Paulo: Roca; 2007. p. 7-28.
11. Instituto Brasileiro de Geografa e Estatística (IBGE). Análise da disponibilidade domiciliar de alimentos do estado nutricional no Brasil. Disponível em: www.ibge.com.br. Acesso em: Nov 24, 2006.
12. Ferreira A P, Oliveira CE, França NM. Metabolic syndrome and risk factors for cardiovascular disease in obese children: the relationship with insulin resistance (HOMA-IR). J Pediatr (Rio J). 2007;83(1):21-6.
13. Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: The Bogalusa Heart Study. Pediatrics. 2001;108(3):712-8.
14. Goodman E, Daniels SR, Morrison JA, Huang GB, Dolan LM. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III defnitions of metabolic syndrome among adolescents. J Pediatr. 2004:145(4):445-51.
15. Duncan GE, Perri MG, Theriaque DW, Hutson AD, Eckel RH, Stac-poole PW. Exercise training, without weight loss, increases insulin sensitivity and postheparin plasm lipase activity on previously sedentary adults. Diabetes Care. 2003;26(3):557-62.
16. Goodman E, Whitaker RC. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics. 2002;110(3):497-504.
17. World Health Organization. Defnition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: Department of Noncommunicable Disease Surveillance; 1999. p. 31-3.
18. Anderson PJ, Critchley JA, Chan JC, Corkram CL, See ZS, Thomas GN, et al. Factor analysis of the metabolic syndrome: obesity vs insulin resistence as the central abnormality. Int Obes Relat Me-tas Disord. 2001;25(12):1782-8.
19. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, Mc-Crindle B, et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientifc statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young: Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009;119:628-47.
20. Griffn JE, Ojeda SE. Textbook of endocrine physiology. 5.ed. Oxford: Oxford University Press; 2004.
21. Center for Disease Control and Prevention (CDC). National Center for Health Statistics; 2000.
22. Lottenberg SA, Glezer A, Turatti LA. Metabolic syndrome: identifying the risk factors. J Pediatr (Rio J). 2007;83(5 Suppl):S204-8.
23. Franco RR, Fuks FB, Damiani D. Síndrome metabólica: prevenin-do complicações a longo prazo. In: Damiani D. Endocrinologia na Prática Pediátrica. 2.ed. Barueri, SP: Manole; 2011. p. 70-87.
24. Saad MJ, Velloso LA, Carvalho CR. Angiotensin II induces tyrosi-ne phosphorylation of insulin receptor substrate 1 and its association with hosphatidylinositol 3-kinase in rat heart. Biochem J. 1995;310(3):741-4.
25. Carvalheira JB, Calegari VC, Zecchin HG, Nadruz W Jr, Guima-rães RD, Ribeiro EB, et al. The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kina-se- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance. Endocrinology. 2003;144:5604-14.
26. Andreozzi F, Laratta E, Sciacqua A, Perticone F, Sesti G. Angioten-sin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endo-thelial cells. Circ Res. 2004;94:1211-8.
27. Scott M, Grundy MD, Bryan BJ, James L, Sidney C. Definition of metabolic syndrome: Report of the National Heart, lung, and blood institute/ American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-8.
28. American Diabetes Association. Diagnosis and Classifcation of Diabetes Mellitus. Diabetes Care. 2004;27(Suppl1)55:S10.
29. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodeman G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865-73.
30. Browning JD, Horton JD. Molecular mediators of hepatic steato-sis and liver injury. J Clin Invest. 2004;114:147-52.